Lisinopril prescribing across the NHS.
Lisinopril is America's favourite ACE inhibitor and England's also-ran: 7.5m items a year here against ramipril's 36.4m. Same class, same job, same generic pennies; the gap is formulary history, not evidence. It is drifting gently down as the ARBs pull patients away.
The NHS in England dispensed 7,436,926 prescription items of Lisinopril in the 12 months to July 2026, across primary care and hospitals.
Spending on Lisinopril over those 12 months was £8.7m at net ingredient cost, the list price of what was dispensed before any discounts.
Items were down 2.0% on the previous 12 months.
98% of Lisinopril volume moved through primary care and 2% through hospital pharmacies.
Lisinopril ranks #2 of 12 chemical substances in Angiotensin-converting enzyme inhibitors (BNF 2.5.5.1), by items dispensed.
Among Integrated Care Boards, NHS North East and North Cumbria ICB dispensed the highest volume of Lisinopril.
Source: NHS Business Services Authority open data (English Prescribing Data and SCMD), OGL v3.0. Items count prescriptions dispensed, not patients treated.
Diamond markers show events around this period: NICE decisions, safety alerts, supply notices, Drug Tariff moves and price concessions, new suppliers in dm+d and framework awards. Hover a marker for the date and type. The evidence behind each one, with the source quote and link, sits behind Apply.
| Month | Items | Spend (NIC) |
|---|---|---|
| July 2026 | 647,457 | £1.2m |
| June 2026 | 621,938 | £1.1m |
| May 2026 | 599,288 | £797k |
| April 2026 | 614,558 | £671k |
| March 2026 | 628,512 | £612k |
| February 2026 | 574,194 | £557k |
| January 2026 | 622,939 | £609k |
| December 2025 | 655,693 | £665k |
| November 2025 | 594,697 | £603k |
| October 2025 | 645,567 | £645k |
| September 2025 | 628,653 | £638k |
| August 2025 | 603,430 | £605k |
The same series as the chart, most recent month first. The full monthly history, as CSV, sits behind Apply.
15.1% of its class.
Lisinopril ranks #2 of 12 chemical substances in Angiotensin-converting enzyme inhibitors (BNF 2.5.5.1), by items dispensed in July 2026. The full class league, who's gaining, and the month-by-month share movement sit behind Apply.
Average items by calendar month across the full history, indexed to the annual mean.
25 suppliers hold a live lisinopril listing, across 101 packs.
A A H Pharmaceuticals Ltd, Accord-UK Ltd, Alliance Healthcare (Distribution) Ltd, Almus Pharmaceuticals Ltd, Atnahs Pharma UK Ltd, Bristol Laboratories Ltd, Brown & Burk UK Ltd, Crescent Pharma Ltd, CST Pharma Ltd, Drug Tariff Special Order, Genesis Pharmaceuticals Ltd, Lexon (UK) Ltd, Medihealth (Northern) Ltd, Medreich Plc, Milpharm Ltd, Noumed Life Sciences Ltd, Phoenix Healthcare Distribution Ltd, Relonchem Ltd, Roma Pharmaceuticals Ltd, Rosemont Pharmaceuticals Ltd, Sigma Pharmaceuticals Plc, Special Order, Teva UK Ltd, Unicorn Pharmaceuticals Ltd, Viatris UK Healthcare Ltd. In the last twelve months 0 packs were listed and 7 discontinued. Every pack, its GTIN and published list price, and each week's changes are in the full report.
A listing in the NHS Dictionary of Medicines and Devices means a product may be supplied. It says nothing about sales or market share, and the list price is the reimbursement price, not what any buyer pays. Contains information from dm+d 10.1.0, published by the NHS Business Services Authority under the Open Government Licence v3.0.
Lisinopril across all 36 ICBs.
Every Integrated Care Board in England, shaded by how much lisinopril its GPs dispense per head of population. Hover an ICB to name it. The ranked figures for all 36 ICBs, and the drill-down to practice level, are in the full report.
Darker shading marks where Lisinopril is dispensed most per head of population. Exact figures for every ICB, and the drill-down to practice level, are in the full report.
Zoomed out to the 7 NHS regions.
The same 12 months rolled up to NHS England's seven regions, ranked by intensity.
The teaser view.
Three rows each. The full 36-ICB view, every prescribing organisation, every strength and the hospital picture sit below the fold, behind Apply.
- 1 NHS North East and North Cumbria ICB 1.2m
- 2 NHS Greater Manchester ICB 586k
- 3 NHS Central East ICB 556k
- – + 33 more. See the full 36-ICB table. See all →
- 1 NHS Greater Manchester ICB +6.8%
- 2 NHS Essex ICB +1.2%
- 3 NHS Dorset ICB +0.5%
- – + 33 more. See every ICB, ranked. See all →
- 1 Lisinopril 20mg tablets 35%
- 2 Lisinopril 10mg tablets 33%
- 3 Lisinopril 5mg tablets 21%
- – + 3 more. See every strength and pack. See all →
Split of items across NHSBSA primary care and SCMD hospital dispensing.
Prescribing by deprivation.
Items per 1,000 registered patients by deprivation decile (1 = most deprived), practice deprivation weighted by where each practice's patients live. Read the shape rather than the absolute level: the most and least deprived deciles cover far fewer practices, and age structure drives much of the gradient.
The devolved nations.
| Nation | Items · 12 months | Data to |
|---|---|---|
| England | 7.4m | July 2026 |
| Scotland | 923k | June 2026 |
| Northern Ireland | 221k | May 2026 |
| Wales | 465k | April 2026 |
Each nation publishes its own community prescribing data, with different coding and list rules, so read these per-nation rather than as an exact UK total. Sources: NHSBSA (England), Public Health Scotland, NHS Wales Shared Services Partnership, OpenDataNI. Used under the Open Government Licence v3.0.
What open data won't tell you about lisinopril.
Cost is list price on a thoroughly generic molecule, and the item count cannot say whether a prescription is decades-old maintenance or a new start.
Asked and answered.
Is lisinopril prescribing rising or falling in the NHS?
Falling. England dispensed 7,436,926 items of Lisinopril in the 12 months to July 2026, down 2.0% on the previous 12 months. Items count prescriptions dispensed, not patients treated, so the change can reflect dose and duration shifts as well as patient numbers.
How much does the NHS spend on lisinopril?
£8.7m at net ingredient cost in the 12 months to July 2026. Net ingredient cost is the list price of the medicine before discounts and rebates; the NHS's final bill, especially for hospital medicines, is usually lower.
Where in England is lisinopril prescribed most?
By raw volume, NHS North East and North Cumbria ICB dispensed the most lisinopril in the last 12 months. Raw volume favours the biggest populations; the map on this page shades every ICB by items per head to correct for that.
How up to date is this data?
This page runs to July 2026, the most recent NHSBSA release. Prescribing data publishes roughly six to eight weeks in arrears, and DoseTrend refreshes within 48 hours of each monthly release.
The full breakdown.
Every ICB, every prescribing organisation, every strength, the hospital view with what trusts paid and who holds each framework line, Signals with their sources, and the monthly briefing PDF. The rows below are placeholders; the real tables sit behind the application.
Related pages.
See the full molecule directory, or read about the data and pricing.
Track lisinopril like this, every month.
£1,500 a month per molecule. Apply and we'll pre-fill Lisinopril for you.